Literature DB >> 19289525

Activities of ceftobiprole and other cephalosporins against extracellular and intracellular (THP-1 macrophages and keratinocytes) forms of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

Sandrine Lemaire1, Youri Glupczynski, Valérie Duval, Bernard Joris, Paul M Tulkens, Françoise Van Bambeke.   

Abstract

Staphylococcus aureus is an opportunistic intracellular organism. Although they poorly accumulate in eukaryotic cells, beta-lactams show activity against intracellular methicillin (methicillin)-susceptible S. aureus (MSSA) if the exposure times and the drug concentrations are sufficient. Intraphagocytic methicillin-resistant S. aureus (MRSA) strains are susceptible to penicillins and carbapenems because the acidic pH favors the acylation of PBP 2a by these beta-lactams through pH-induced conformational changes. The intracellular activity (THP-1 macrophages and keratinocytes) of ceftobiprole, which shows almost similar in vitro activities against MRSA and MSSA in broth, was examined against a panel of hospital-acquired and community-acquired MRSA strains (MICs, 0.5 to 2.0 mg/liter at pH 7.4 and 0.25 to 1.0 mg/liter at pH 5.5) and was compared with its activity against MSSA isolates. The key pharmacological descriptors {relative maximal efficacy (E(max)), relative potency (the concentration causing a reduction of the inoculum halfway between E(0) and E(max) [EC(50)]), and static concentration (C(s))} were measured. All strains showed sigmoidal dose-responses, with E(max) being about a 1 log(10) CFU decrease from the postphagocytosis inoculum, and EC(50) and C(s) being 0.2 to 0.3x and 0.6 to 0.9x the MIC, respectively. Ceftobiprole effectively competed with Bocillin FL (a fluorescent derivative of penicillin V) for binding to PBP 2a at both pH 5.5 and pH 7.4. In contrast, cephalexin, cefuroxime, cefoxitin, or ceftriaxone (i) were less potent in PBP 2a competitive binding assays, (ii) showed only partial restoration of the activity against MRSA in broth at acidic pH, and (iii) were collectively less effective against MRSA in THP-1 macrophages and were ineffective in keratinocytes. The improved activity of ceftobiprole toward intracellular MRSA compared with the activities of conventional cephalosporins can be explained, at least in part, by its greater ability to bind to PBP 2a not only at neutral but also at acidic pH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289525      PMCID: PMC2687181          DOI: 10.1128/AAC.01135-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

Review 1.  Community-associated methicillin-resistant Staphylococcus aureus: overview and local situation.

Authors:  Limin Wijaya; Li-Yang Hsu; Asok Kurup
Journal:  Ann Acad Med Singapore       Date:  2006-07       Impact factor: 2.473

Review 2.  Meticillin-resistant Staphylococcus aureus in animals: a review.

Authors:  F C Leonard; B K Markey
Journal:  Vet J       Date:  2007-01-09       Impact factor: 2.688

3.  Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.

Authors:  Maritza Barcia-Macay; Sandrine Lemaire; Marie-Paule Mingeot-Leclercq; Paul M Tulkens; Françoise Van Bambeke
Journal:  J Antimicrob Chemother       Date:  2006-10-24       Impact factor: 5.790

4.  Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.

Authors:  Sandrine Lemaire; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  J Antimicrob Chemother       Date:  2005-04-28       Impact factor: 5.790

5.  In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.

Authors:  P Hebeisen; I Heinze-Krauss; P Angehrn; P Hohl; M G Page; R L Then
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

6.  Reaction of soluble penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus with beta-lactams and acyclic substrates: kinetics in homogeneous solution.

Authors:  K Graves-Woodward; R F Pratt
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

Review 7.  The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.

Authors:  Stanley C Deresinski
Journal:  Diagn Microbiol Infect Dis       Date:  2008-04-02       Impact factor: 2.803

Review 8.  Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.

Authors:  George Sakoulas; Robert C Moellering
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

9.  Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.

Authors:  Cristina Seral; Françoise Van Bambeke; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

10.  Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: the potential role of daptomycin.

Authors:  David M Bamberger
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

View more
  15 in total

Review 1.  Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.

Authors:  Daniel Gonzalez; Stephan Schmidt; Hartmut Derendorf
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

2.  Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila.

Authors:  Sandrine Lemaire; Klaudia Kosowska-Shick; Peter C Appelbaum; Gunther Verween; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2010-04-12       Impact factor: 5.191

Review 3.  Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.

Authors:  Yahiya Y Syed
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

Review 4.  Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?

Authors:  Guy E Thwaites; Vanya Gant
Journal:  Nat Rev Microbiol       Date:  2011-02-07       Impact factor: 60.633

5.  Cellular pharmacokinetics and intracellular activity of the novel peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus laboratory and clinical strains with various resistance phenotypes: studies with human THP-1 monocytes and J774 murine macrophages.

Authors:  Frédéric Peyrusson; Deborah Butler; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

6.  Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development.

Authors:  Nina M van Sorge; Federico C Beasley; Ivan Gusarov; David J Gonzalez; Maren von Köckritz-Blickwede; Sabina Anik; Andrew W Borkowski; Pieter C Dorrestein; Evgeny Nudler; Victor Nizet
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

7.  Activity of ceftaroline against Enterococcus faecium PBP5.

Authors:  Xavier Henry; Oliver Verlaine; Ana Amoroso; Jacques Coyette; Jean-Marie Frère; Bernard Joris
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

8.  Interaction of ceftobiprole with the low-affinity PBP 5 of Enterococcus faecium.

Authors:  Xavier Henry; Ana Amoroso; Jacques Coyette; Bernard Joris
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

9.  Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections.

Authors:  L G Garcia; S Lemaire; B C Kahl; K Becker; R A Proctor; O Denis; P M Tulkens; F Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

10.  New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria.

Authors:  Samo Turk; Olivier Verlaine; Thomas Gerards; Matej Zivec; Jan Humljan; Izidor Sosič; Ana Amoroso; Astrid Zervosen; André Luxen; Bernard Joris; Stanislav Gobec
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.